Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
6.19
-0.39 (-5.93%)
At close: Jul 24, 2026, 4:00 PM EDT
6.28
+0.09 (1.45%)
After-hours: Jul 24, 2026, 7:37 PM EDT

Journey Medical Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
64.0261.8656.1379.1873.6763.13
Revenue Growth
15.89%10.20%-29.11%7.48%16.69%41.77%
Gross Profit
41.6740.9335.2656.2942.8931.05
Operating Income
-6.34-8.17-13.68-2.07-27.52-34.88
Net Income
-9.59-11.43-14.67-3.85-29.63-43.99
Earnings Per Share
-0.37-0.47-0.72-0.21-1.69-4.32
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
27.2224.0920.3127.443249.08
Total Debt
25.4725.425.0814.7322.970.91
Net Cash (Debt)
1.75-1.31-4.7812.719.0448.17
Net Cash Growth
---40.62%-81.24%1593.78%
Net Cash Per Share
0.07-0.05-0.230.700.524.73

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-0.42-12.44-9.135.24-13.53-2.18
Free Cash Flow
-0.42-12.44-9.135.24-13.53-2.18
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
65.09%66.17%62.81%71.09%58.23%49.18%
Operating Margin
-9.90%-13.21%-24.36%-2.62%-37.35%-55.25%
Pretax Margin
-14.88%-18.38%-26.03%-4.59%-40.13%-67.10%
Profit Margin
-14.98%-18.48%-26.14%-4.87%-40.22%-69.68%
FCF Margin
-0.65%-20.11%-16.26%6.62%-18.37%-3.45%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
41.9761.68----
P/FCF Ratio
---21.24--
PS Ratio
2.643.381.541.410.461.48